Hims and Hers CEO on Growth Beyond Sex Medication

Voices of Wall Street
February 6, 2021
Hims and Hers Health, the telemedicine company best-known for its cheeky advertisements about its sexual health treatments, is determined to be a major player in the $4 trillion U.S. healthcare industry.

Andrew Dudum, co-founder and CEO of Hims and Hers Health, spoke with "Voices of Wall Street" about the successful SPAC that brought the company to the public markets, the next wave of growth beyond ED medication, the future of telemedicine, competition with Teledoc and Roman, the inefficiencies with the current healthcare system, and his outlook for healthcare under President Biden.

For more on Andrew Dudum and Hims and Hers Health, visit:

For more on "Voices of Wall Street," visit their website and Twitter:
Bullish is a conversation about money for the curious. Earn more, spend smarter and grow your money it a way that's right for you.

Follow Bullish:
partner with us